Assessing the Clinical Value of Cannabis-Based Treatments on Fibromyalgia Pain
Hendrickson, Blake, et al.
Journal of Psychological Inquiry. 2013, 18(2): 6-14 (Full).
Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials
Lynch, Mary E, et al.
British Journal of Clinical Pharmacology. 2011 Oct 11, 72(5): 735-744 (Full).
Cannabis Use in Patients with Fibromyalgia: Effect on Symptoms Relief and Health-Related Quality of Life
Fiz, Jimena, et al.
PlosOne, 2011 Apr 21, (online article).
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial
Ware, Mark A, et al.
CMAJ. 2010 Oct 5, 182(14) (online article).
The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial
Ware, Mark A, et al.
Anesthesia & Analgesia. 2010 Feb, 110(2): 604-610 (Full).
Tetrahydrocannabinol (Delta 9-THC) Treatment in Chronic Central Neuropathic Pain and Fibromyalgia Patients: Results of a Multicenter Survey
Weber, Janet, et al.
Anesthesiology Research and Practice. 2009, (online article).
Cannabinoids and Pain
King, Steven A.
Rheumatology Network. 2008 Feb 1, (online article).
The Pharmacological and Clinical Effects of Medical Cannabis
Borgelt, Laura M, et al.
Pharmacotherapy. 2013 Feb 5, 33(2): 195-209 (abstract).
Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State
Aggarwal, SK, et al.
Journal of Opioid Management. 2009, 5(5): 257-286 (abstract).
Future of Cannabis and Cannabinoids in Therapeutics
Russo, Ethan B.
Journal of Cannabis Therapeutics. 2008 Oct 15, 3(4): 163-174 (abstract).
Nabilone for the Treatment of Pain in Fibromyalgia
Skrabek, Ryan Quinlan, et al.
The Journal of Pain. 2008 Feb, 9(2): 164-173 (abstract).
Cannabis, Pain, and Sleep: Lessons from Therapeutic Clinical Trials of Sativex, a Cannabis-Based Medicine
Russo, Ethan B, et al.
Chemistry & Biodiversity. 2007 Aug 21, 4(8): 1729-1743 (abstract).
Delta-9 THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief
Schley, Marcus, et al.
Current Medical Research and Opinion. 2006, 22(7): 1269-1276 (abstract).
Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?
Neuro Endocrinology Letters. 2004, 25(1-2): 31-39 (abstract).